<DOC>
	<DOCNO>NCT01531647</DOCNO>
	<brief_summary>This open-label , multiple dose , single sequence crossover study evaluate drug-drug interaction danoprevir/low-dose ritonavir raltegravir healthy volunteer . Subjects receive raltegravir Days 1-4 , washout period 3 day , danoprevir low-dose ritonavir Days 8-21 , combination raltegravir Days 18-21 .</brief_summary>
	<brief_title>A Study Drug-Drug Interaction Between Danoprevir/Low-Dose Ritonavir Raltegravir Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<mesh_term>Lactams</mesh_term>
	<criteria>Healthy nonsmoking male female adult , 18 55 year age , inclusive Healthy status define absence evidence active chronic disease Medical history without major , recent , ongoing pathology Weight &gt; /= 50.0 kg Body mass index ( BMI ) 18.0 320 kg/m2 Willingness abstain alcohol , xanthinecontaining beverage food ( e.g . coffee , tea , cola , chocolate , `` energy drink '' ) 48 hour prior entry clinical site discharge Females childbearing potential male female partner childbearing potential must agree use 2 form contraception , one must barrier method , study 90 day last drug administration . Acceptable barrier form contraception condom diaphragm ; acceptable nonbarrier form contraception study nonhormonal intrauterine device ( IUD ) and/or spermicide Pregnant lactating female male female partner pregnant lactate Any history clinically significant cardiovascular cerebrovascular disease , hypertension , and/or infection Positive test drug abuse screen prior admission clinical site study period Positive hepatitis B , hepatitis C HIV infection Current smoker subject discontinue smoke less 6 month prior first dose study medication Use hormonal contraceptive within 30 day first dose study medication History clinically significant drugrelated allergy ( anaphylaxis ) hepatotoxicity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>